![clincloud](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_03-min-1024x1024.jpg)
August 11, 2020
FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s
Facebook
Twitter
LinkedIn